FDA Approved: VERZENIO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approves a supplemental application for VERZENIO (abemaciclib) submitted by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

SUPPL AP for VERZENIO (ABEMACICLIB)